Is a complete AUTL research report available?

No complete published report is available for Autolus Therapeutics plc (AUTL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · USD

$1.63

+0.08 (+5.2%)· Recorded snapshot

Market cap	433.8M
Revenue (ttm)	117.4M
Net income (ttm)	-280.2M
EPS (ttm)	-$1.05
Shares out	266.2M
Volume	1,299,903
Beta	2.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 117.4M
Net income (ttm): -280.2M
EPS (ttm): -$1.05
Market cap: 433.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001730463
Company name	Autolus Therapeutics plc
Country	United Kingdom
Country code	US
CUSIP number	05280R100
Earnings date	2026-11-10
Earnings time	bmo
Employees	754
Employees change	104
Employees growth	16%
Enterprise value	$600M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Biotechnology
IPO date	2018-06-22
Is primary listing	Yes
Is SPAC	No
ISIN number	US05280R1005
Last 10-K release date	2026-03-27
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$433.8M
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$1.63
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	AUTL
Website	https://www.autolus.com

Metric

Value

Amount currency

USD

CIK code

0001730463

Company name

Autolus Therapeutics plc

Country

United Kingdom

Country code

CUSIP number

05280R100

Earnings date

2026-11-10

Earnings time

bmo

Employees

754

Employees change

104

Employees growth

16%

Enterprise value

$600M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

Industry

Biotechnology

IPO date

2018-06-22

Is primary listing

Yes

Is SPAC

ISIN number

US05280R1005

Last 10-K release date

2026-03-27

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$433.8M

Market cap category

Small-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$1.63

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

AUTL

Website

https://www.autolus.com

Metric	Value
Earnings yield	-64.58%
EV/Sales	5.1x
FCF / EV yield	-38.87%
FCF yield	-53.81%
Forward EV/Sales	3.68x
Forward P/S	2.66x
P/B ratio	5.51x
P/S ratio	3.68x
Price / tangible book value	7.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-64.58%

EV/Sales

5.1x

FCF / EV yield

-38.87%

FCF yield

-53.81%

Forward EV/Sales

3.68x

Forward P/S

2.66x

P/B ratio

5.51x

P/S ratio

3.68x

Price / tangible book value

7.68x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-210.49%
EBITDA margin	-201.53%
Gross margin	-74.6%
Operating margin	-210.49%
Pretax margin	-238.08%
Profit margin	-238.65%
Profit per employee	$-371,560
Revenue per employee	$155,690
ROA	-25.44%
ROA (5Y)	-24.2%
ROCE	-58.22%
ROE	-133%
ROE (5Y)	-76.29%
ROIC	-28.12%
SBC / revenue	13.15%
Tax / revenue	0.58%

Metric

Value

EBIT margin

-210.49%

EBITDA margin

-201.53%

Gross margin

-74.6%

Operating margin

-210.49%

Pretax margin

-238.08%

Profit margin

-238.65%

Profit per employee

$-371,560

Revenue per employee

$155,690

ROA

-25.44%

ROA (5Y)

-24.2%

ROCE

-58.22%

ROE

-133%

ROE (5Y)

-76.29%

ROIC

-28.12%

SBC / revenue

13.15%

Tax / revenue

0.58%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth	292.16%
Revenue growth (Q)	118.37%
Revenue growth (QoQ)	74.27%
Revenue growth 3Y	150.3%
Revenue growth 5Y	108.24%
Revenue growth quarters	3
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

292.16%

Revenue growth (Q)

118.37%

Revenue growth (QoQ)

74.27%

Revenue growth 3Y

150.3%

Revenue growth 5Y

108.24%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-7.1M
Depreciation and amortization	$10.5M
EBIT	$-247.1M
EBITDA	$-236.6M
EPS	$-1.05
FCF per share	$-0.87
Financing cash flow	$-7.8M
Free cash flow	$-232.7M
Free cash flow minus SBC	$-248.2M
Gross profit	$-87.6M
Income taxes	$677,000
Investing cash flow	$286.1M
Net cash flow	$47.6M
Net income	$-280.2M
Operating cash flow minus SBC	$-241M
Operating income	$-247.1M
Revenue	$117.4M
Stock-based compensation	$15.4M

Metric

Value

Capital expenditures

$-7.1M

Depreciation and amortization

$10.5M

EBIT

$-247.1M

EBITDA

$-236.6M

EPS

$-1.05

FCF per share

$-0.87

Financing cash flow

$-7.8M

Free cash flow

$-232.7M

Free cash flow minus SBC

$-248.2M

Gross profit

$-87.6M

Income taxes

$677,000

Investing cash flow

$286.1M

Net cash flow

$47.6M

Net income

$-280.2M

Operating cash flow minus SBC

$-241M

Operating income

$-247.1M

Revenue

$117.4M

Stock-based compensation

$15.4M

Metric	Value
Altman Z-Score	-4.39
Book value per share	$0.28
Debt / equity	4.91
Interest coverage	-5.47
Long-term assets	$157.1M
Long-term liabilities	$349.6M
Net cash (debt)	$-166.2M
Net cash / market cap	-38.42%
Net debt / equity	2.22
Piotroski F-Score	3
Property, plant and equipment	$134.6M
Shareholders' equity	$74.8M
Tangible book value	$56.3M
Tangible book value per share	$0.21
Total assets	$493.2M
Total cash	$201.6M
Total debt	$367.8M
Total liabilities	$418.4M
WACC	13.13%

Metric

Value

Altman Z-Score

-4.39

Book value per share

$0.28

Debt / equity

4.91

Interest coverage

-5.47

Long-term assets

$157.1M

Long-term liabilities

$349.6M

Net cash (debt)

$-166.2M

Net cash / market cap

-38.42%

Net debt / equity

2.22

Piotroski F-Score

Property, plant and equipment

$134.6M

Shareholders' equity

$74.8M

Tangible book value

$56.3M

Tangible book value per share

$0.21

Total assets

$493.2M

Total cash

$201.6M

Total debt

$367.8M

Total liabilities

$418.4M

WACC

13.13%

Metric	Value
Asset turnover	0.19
Current assets	$336.1M
Current liabilities	$68.8M
Current ratio	4.89
Inventory turnover	7.14
Net working capital	$84.4M
Quick ratio	4.06
Working capital	$267.3M
Working capital turnover	0.3

Metric

Value

Asset turnover

0.19

Current assets

$336.1M

Current liabilities

$68.8M

Current ratio

4.89

Inventory turnover

7.14

Net working capital

$84.4M

Quick ratio

4.06

Working capital

$267.3M

Working capital turnover

0.3

Metric	Value
Buyback yield / dilution	-2.1%
Dividend yield	0%
Shareholder yield	-2.1%

Metric

Value

Buyback yield / dilution

-2.1%

Dividend yield

Shareholder yield

-2.1%

Metric	Value
150-day SMA	$1.72
1D price change	5.16%
1M price change	-14.02%
1M total return	-14.02%
1W price change	-3.92%
1W total return	-3.92%
1Y price change	-3.33%
1Y return CAGR	-3.34%
1Y total return	-3.33%
20-day SMA	$1.68
200-day SMA	$1.66
3M price change	9.25%
3M total return	9.25%
3Y price change	-39.58%
3Y return CAGR	-15.46%
3Y total return	-39.58%
50-day SMA	$1.94
50-day SMA vs 200-day SMA	50over200
52-week high	$2.58
52-week high date	2026-08-19
52-week low	$1.18
52-week low date	2026-03-27
5Y price change	-71.52%
5Y return CAGR	-22.21%
5Y total return	-71.52%
6M price change	12.32%
6M total return	12.32%
All-time high	$53.24
All-time high date	2018-11-09
All-time low	$1.11
All-time low date	2025-04-11
Average true range (ATR)	$0.09
Average volume	1.8M
Beta (1Y)	3.62
Beta (2Y)	1.96
Beta (5Y)	2.14
Change from 52-week high	-36.82%
Change from 52-week low	38.72%
Change from all-time high	-97%
Change from all-time low	44.34%
Change from open	5.16%
Day's gap	0%
Dollar volume	$2.1M
High price	$1.63
Low price	$1.52
Monthly RSI	44.7
Open price	$1.55
Position in 52-week range	100%
Premarket change	-0.54%
Premarket close	$1.55
Premarket price	$1.54
Premarket volume	31.9K
Previous close	$1.55
Price vs 150-day SMA	-7.38%
Price vs 20-day SMA	-5.29%
Price vs 200-day SMA	-4.15%
Price vs 50-day SMA	-17.95%
Relative volume	0.74
RSI	39.95
Sharpe ratio	0.27
Sharpe ratio (3Y)	0.12
Sharpe ratio (5Y)	0.01
Sortino ratio	0.5
Sortino ratio (3Y)	0.26
Sortino ratio (5Y)	0.09
Volume	1.3M
Weekly RSI	45.08
YTD price change	-19.85%
YTD total return	-19.85%

Metric

Value

150-day SMA

$1.72

1D price change

5.16%

1M price change

-14.02%

1M total return

-14.02%

1W price change

-3.92%

1W total return

-3.92%

1Y price change

-3.33%

1Y return CAGR

-3.34%

1Y total return

-3.33%

20-day SMA

$1.68

200-day SMA

$1.66

3M price change

9.25%

3M total return

9.25%

3Y price change

-39.58%

3Y return CAGR

-15.46%

3Y total return

-39.58%

50-day SMA

$1.94

50-day SMA vs 200-day SMA

50over200

52-week high

$2.58

52-week high date

2026-08-19

52-week low

$1.18

52-week low date

2026-03-27

5Y price change

-71.52%

5Y return CAGR

-22.21%

5Y total return

-71.52%

6M price change

12.32%

6M total return

12.32%

All-time high

$53.24

All-time high date

2018-11-09

All-time low

$1.11

All-time low date

2025-04-11

Average true range (ATR)

$0.09

Average volume

1.8M

Beta (1Y)

3.62

Beta (2Y)

1.96

Beta (5Y)

2.14

Change from 52-week high

-36.82%

Change from 52-week low

38.72%

Change from all-time high

-97%

Change from all-time low

44.34%

Change from open

5.16%

Day's gap

Dollar volume

$2.1M

High price

$1.63

Low price

$1.52

Monthly RSI

44.7

Open price

$1.55

Position in 52-week range

100%

Premarket change

-0.54%

Premarket close

$1.55

Premarket price

$1.54

Premarket volume

31.9K

Previous close

$1.55

Price vs 150-day SMA

-7.38%

Price vs 20-day SMA

-5.29%

Price vs 200-day SMA

-4.15%

Price vs 50-day SMA

-17.95%

Relative volume

0.74

RSI

39.95

Sharpe ratio

0.27

Sharpe ratio (3Y)

0.12

Sharpe ratio (5Y)

0.01

Sortino ratio

0.5

Sortino ratio (3Y)

0.26

Sortino ratio (5Y)

0.09

Volume

1.3M

Weekly RSI

45.08

YTD price change

-19.85%

YTD total return

-19.85%

Metric	Value
Float	102.9M
Float percentage	38.67%
Shares change (QoQ)	0.01%
Shares change (YoY)	2.1%
Shares held by insiders	0.83%
Shares held by institutions	18.92%
Shares outstanding	266.2M
Short % of shares	4.87%
Short ratio	5.3 days

Metric

Value

Float

102.9M

Float percentage

38.67%

Shares change (QoQ)

0.01%

Shares change (YoY)

2.1%

Shares held by insiders

0.83%

Shares held by institutions

18.92%

Shares outstanding

266.2M

Short % of shares

4.87%

Short ratio

5.3 days

Autolus Therapeutics plc (AUTL)

Price

Financial snapshot

Fair-value bridge

Latest news · AUTL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AUTL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AUTL

Frequently asked questions